{"id":5214,"date":"2023-05-09T08:33:00","date_gmt":"2023-05-09T06:33:00","guid":{"rendered":"https:\/\/www.amyloidosisalliance.org\/det-4e-europeiska-motet-om-attr-amyloidos\/"},"modified":"2026-11-03T10:46:25","modified_gmt":"2026-11-03T09:46:25","slug":"det-4e-europeiska-motet-om-attr-amyloidos","status":"publish","type":"post","link":"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/","title":{"rendered":"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos"},"content":{"rendered":"\n<p class=\"has-black-color has-text-color wp-block-paragraph\">Det 4:e europeiska m\u00f6tet om ATTR-amyloidos f\u00f6r patienter och l\u00e4kare h\u00e5lls den 2 och 3 november. Anm\u00e4l dig p\u00e5 evenemangets officiella webbplats: <a href=\"https:\/\/attramyloidosis2023.com\" target=\"_blank\" rel=\"noreferrer noopener\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0);color:#f2a670\" class=\"has-inline-color\">www.attramyloidosis2023.com<\/mark><\/strong><\/a><\/p>\n\n<p class=\"wp-block-paragraph\">M\u00f6tet h\u00e5lls b\u00e5de p\u00e5 plats och digitalt, med ett program f\u00f6r l\u00e4kare och ett f\u00f6r patienter.<\/p>\n\n<h2 class=\"wp-block-heading\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-light-green-cyan-color\">Syfte<\/mark><\/h2>\n\n<p class=\"wp-block-paragraph\">M\u00f6tet vill sammanf\u00f6ra patienternas behov och de framsteg som gjorts f\u00f6r dem. Vi kommer att kunna utbyta behov och kunskap om amyloidos. V\u00e4lk\u00e4nda l\u00e4kare inom omr\u00e5det deltar f\u00f6r att ber\u00e4tta om sina framsteg och lyssna p\u00e5 patienterna:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>prof. Pablo Garcia-Pavia, Madrid<\/li>\n\n\n\n<li>dr Esther Gonzalez-Lopez, Madrid<\/li>\n\n\n\n<li>prof. Julian Gillmore, London<\/li>\n\n\n\n<li>prof. David Adams, Frankrike<\/li>\n\n\n\n<li>prof. Thibaud Damy, Frankrike<\/li>\n\n\n\n<li>dr Laura Obici, Italien<\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-light-green-cyan-color\">Program<\/mark><\/h2>\n\n<p class=\"wp-block-paragraph\"><strong>Torsdag 2 november<sup><\/sup>:<\/strong><\/p>\n\n<ul class=\"wp-block-list\">\n<li>Inledning av en f\u00f6retr\u00e4dare f\u00f6r det spanska h\u00e4lsoministeriet<\/li>\n\n\n\n<li>Vardagen med amyloidos<\/li>\n\n\n\n<li>Bli en engagerad patient<\/li>\n\n\n\n<li>4 inslag f\u00f6r l\u00e4kemedelsf\u00f6retag<\/li>\n\n\n\n<li>St\u00f6dn\u00e4tverk f\u00f6r n\u00e4rst\u00e5ende<\/li>\n\n\n\n<li>Att tala om amyloidos<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\"><strong>Fredag 3 november<sup><\/sup>:<\/strong><\/p>\n\n<ul class=\"wp-block-list\">\n<li>Hyllning till prof. Rapezzi<\/li>\n\n\n\n<li>Sponsrat symposium<\/li>\n\n\n\n<li>Att hantera symtomen<\/li>\n\n\n\n<li>Behandlingar av ATTR-amyloidos 2023 och fram\u00e5t<\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-light-green-cyan-color\">Anm\u00e4lan<\/mark><\/h2>\n\n<p class=\"wp-block-paragraph\">Anm\u00e4l dig till evenemanget,<mark style=\"background-color:rgba(0, 0, 0, 0);color:#e4a469\" class=\"has-inline-color\"> <\/mark><a href=\"https:\/\/attramyloidosis2023.com\/registration\/\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0);color:#e09855\" class=\"has-inline-color\">klicka direkt h\u00e4r<\/mark><\/strong><\/a><br\/><br\/>________________________________________________<\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Det 4:e europeiska m\u00f6tet om ATTR-amyloidos f\u00f6r patienter och l\u00e4kare h\u00e5lls den 2 och 3 november 2023, p\u00e5 plats och online, med tv\u00e5 program.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[93],"tags":[],"class_list":["post-5214","post","type-post","status-publish","format-standard","hentry","category-uncategorized-sv"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Det 4:e europeiska m\u00f6tet om ATTR-amyloidos<\/title>\n<meta name=\"description\" content=\"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos f\u00f6r patienter och l\u00e4kare h\u00e5lls den 2 och 3 november 2023, p\u00e5 plats och online, med tv\u00e5 program.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos\" \/>\n<meta property=\"og:description\" content=\"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos f\u00f6r patienter och l\u00e4kare h\u00e5lls den 2 och 3 november 2023, p\u00e5 plats och online, med tv\u00e5 program.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/\" \/>\n<meta property=\"og:site_name\" content=\"Amyloidosis Alliance\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AmyloidosisAlliance\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-09T06:33:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-03T09:46:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/amyloidosisalliance.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@amyloidosisa\" \/>\n<meta name=\"twitter:site\" content=\"@amyloidosisa\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/det-4e-europeiska-motet-om-attr-amyloidos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/det-4e-europeiska-motet-om-attr-amyloidos\\\/\"},\"author\":{\"name\":\"Amyloidosis Alliance\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/#organization\"},\"headline\":\"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos\",\"datePublished\":\"2023-05-09T06:33:00+00:00\",\"dateModified\":\"2026-11-03T09:46:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/det-4e-europeiska-motet-om-attr-amyloidos\\\/\"},\"wordCount\":196,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/#organization\"},\"articleSection\":[\"Okategoriserat\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/det-4e-europeiska-motet-om-attr-amyloidos\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/det-4e-europeiska-motet-om-attr-amyloidos\\\/\",\"name\":\"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/#website\"},\"datePublished\":\"2023-05-09T06:33:00+00:00\",\"dateModified\":\"2026-11-03T09:46:25+00:00\",\"description\":\"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos f\u00f6r patienter och l\u00e4kare h\u00e5lls den 2 och 3 november 2023, p\u00e5 plats och online, med tv\u00e5 program.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/det-4e-europeiska-motet-om-attr-amyloidos\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/det-4e-europeiska-motet-om-attr-amyloidos\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/det-4e-europeiska-motet-om-attr-amyloidos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startsida\",\"item\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/#website\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/\",\"name\":\"Amyloidosis Alliance\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/#organization\",\"name\":\"Amyloidosis Alliance\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"width\":252,\"height\":252,\"caption\":\"Amyloidosis Alliance\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/sv\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AmyloidosisAlliance\\\/\",\"https:\\\/\\\/x.com\\\/amyloidosisa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos","description":"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos f\u00f6r patienter och l\u00e4kare h\u00e5lls den 2 och 3 november 2023, p\u00e5 plats och online, med tv\u00e5 program.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/","og_locale":"sv_SE","og_type":"article","og_title":"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos","og_description":"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos f\u00f6r patienter och l\u00e4kare h\u00e5lls den 2 och 3 november 2023, p\u00e5 plats och online, med tv\u00e5 program.","og_url":"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/","og_site_name":"Amyloidosis Alliance","article_publisher":"https:\/\/www.facebook.com\/AmyloidosisAlliance\/","article_published_time":"2023-05-09T06:33:00+00:00","article_modified_time":"2026-11-03T09:46:25+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/amyloidosisalliance.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_creator":"@amyloidosisa","twitter_site":"@amyloidosisa","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/#article","isPartOf":{"@id":"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/"},"author":{"name":"Amyloidosis Alliance","@id":"https:\/\/www.amyloidosisalliance.org\/sv\/#organization"},"headline":"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos","datePublished":"2023-05-09T06:33:00+00:00","dateModified":"2026-11-03T09:46:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/"},"wordCount":196,"commentCount":0,"publisher":{"@id":"https:\/\/www.amyloidosisalliance.org\/sv\/#organization"},"articleSection":["Okategoriserat"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/","url":"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/","name":"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos","isPartOf":{"@id":"https:\/\/www.amyloidosisalliance.org\/sv\/#website"},"datePublished":"2023-05-09T06:33:00+00:00","dateModified":"2026-11-03T09:46:25+00:00","description":"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos f\u00f6r patienter och l\u00e4kare h\u00e5lls den 2 och 3 november 2023, p\u00e5 plats och online, med tv\u00e5 program.","breadcrumb":{"@id":"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.amyloidosisalliance.org\/sv\/det-4e-europeiska-motet-om-attr-amyloidos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startsida","item":"https:\/\/www.amyloidosisalliance.org\/sv\/"},{"@type":"ListItem","position":2,"name":"Det 4:e europeiska m\u00f6tet om ATTR-amyloidos"}]},{"@type":"WebSite","@id":"https:\/\/www.amyloidosisalliance.org\/sv\/#website","url":"https:\/\/www.amyloidosisalliance.org\/sv\/","name":"Amyloidosis Alliance","description":"","publisher":{"@id":"https:\/\/www.amyloidosisalliance.org\/sv\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.amyloidosisalliance.org\/sv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/www.amyloidosisalliance.org\/sv\/#organization","name":"Amyloidosis Alliance","url":"https:\/\/www.amyloidosisalliance.org\/sv\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/www.amyloidosisalliance.org\/sv\/#\/schema\/logo\/image\/","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","width":252,"height":252,"caption":"Amyloidosis Alliance"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/sv\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AmyloidosisAlliance\/","https:\/\/x.com\/amyloidosisa"]}]}},"_links":{"self":[{"href":"https:\/\/www.amyloidosisalliance.org\/sv\/wp-json\/wp\/v2\/posts\/5214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.amyloidosisalliance.org\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.amyloidosisalliance.org\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/sv\/wp-json\/wp\/v2\/comments?post=5214"}],"version-history":[{"count":1,"href":"https:\/\/www.amyloidosisalliance.org\/sv\/wp-json\/wp\/v2\/posts\/5214\/revisions"}],"predecessor-version":[{"id":5215,"href":"https:\/\/www.amyloidosisalliance.org\/sv\/wp-json\/wp\/v2\/posts\/5214\/revisions\/5215"}],"wp:attachment":[{"href":"https:\/\/www.amyloidosisalliance.org\/sv\/wp-json\/wp\/v2\/media?parent=5214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/sv\/wp-json\/wp\/v2\/categories?post=5214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/sv\/wp-json\/wp\/v2\/tags?post=5214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}